Related Experiment Videos

Production of erythroid potentiating factor(s) by a human monocytic cell line

Blood
|January 1, 1981
PubMed

Insights

The U-937 cell line produces an erythroid potentiating factor (EPF) that enhances red blood cell formation. It also secretes a distinct inhibitor of granulocyte-macrophage colony growth, offering new research avenues.

Area of Science:

  • Hematology
  • Cell biology
  • Biochemistry

Background:

  • The U-937 human monocytic cell line is known to produce factors influencing hematopoiesis.
  • Previous studies indicated the presence of both stimulatory and inhibitory factors in conditioned media.

Purpose of the Study:

  • To characterize the factors produced by the U-937 cell line that affect human hematopoiesis.
  • To determine if the U-937 cell line produces colony-stimulating factors (CSF) or erythropoietin (Ep).

Main Methods:

  • U-937 conditioned media (serum-containing and serum-free) were analyzed for their effects on hematopoietic progenitor cells in vitro.
  • Dose-dependent effects on erythroid colony formation and granulocyte-macrophage colony-forming units (CFU-GM) were assessed.
  • The stability of factors and the effect of Indomethacin on CFU-GM inhibition were investigated.

Main Results:

  • The U-937 conditioned media contained an erythroid potentiating factor (EPF) that enhanced erythroid colony formation in a dose-dependent manner and was heat-stable.
  • A distinct, heat-labile inhibitor of granulocyte-macrophage (CFU-GM) colony growth was also identified, with its effect reversed by Indomethacin.
  • No colony-stimulating factor (CSF) or erythropoietin (Ep) was detected in the conditioned media.

Conclusions:

  • The U-937 cell line elaborates an EPF independent of CSF or Ep production.
  • This cell line provides a model for studying the biochemical and biological properties of EPF.
  • The identified CFU-GM inhibitor may offer insights into regulating myeloid cell development.

Related Concept Videos